Stereoselective synthesis of sparteine surrogates based on an oxabispidine template

ORGN 77

Duncan M Gill, duncan.gill@astrazeneca.com, Heloïse Holness, and Philip S Keegan. Process R&D, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, United Kingdom
Imines 2 prepared from oxazine amine 1 (prepared from (S)-glycidyl phthalimide in 5 high yielding steps), undergo acid-catalysed cyclisation to give oxabispidine acetals 3, which may be converted to oxabispidines 4 in two steps. The reaction is highly stereoselective, affording a product consistent with a chair-chair transition state where the imine E-geometry is retained, and nucleophile capture takes place on the least hindered face. The reaction may be extended to aliphatic aldehydes bearing α-hydrogens by incorporation of benzotriazole into the reaction with 1, stabilising the imine as its benzotriazole adduct. In this manner 5-tosyloxy pentanal was condensed with 1 to give benzotriazole adduct 5, which underwent double cyclisation to generate 6, the precursor to 7, an oxabispidine analogue of O'Brien's (-)-sparteine surrogate.